Provides for coverage for certain individuals under the 1332 state innovation program.
This bill amends New York’s Social Services Law to expand and refine the state’s 1332 State Innovation Program, a federal Affordable Care Act waiver-based coverage program. It directs the Commissioner of Health to take all actions necessary to obtain and maintain federal approval for the program and any amendments to the waiver, rather than merely authorizing such action. The bill also defines the types of health plans and services that may be offered, including essential health benefits, dental and vision care, certain home- and community-based supports, and access to National Cancer Institute-designated cancer centers in-network at Medicaid-equivalent reimbursement levels.
The bill broadens eligibility for coverage to certain New York residents under age 65 who are not eligible for Medicaid or CHIP, are uninsured or underinsured, and have household income between 133% and 250% of the federal poverty level. It specifically addresses some noncitizens who are ineligible for the Basic Health Program on immigration-status grounds, allowing them to qualify if federal approval is obtained. The bill also establishes premium and cost-sharing rules, including no premiums for enrollees at or below 200% of poverty and capped monthly premiums above that level, along with continuous enrollment, retroactive coverage, and special protections for pregnancy and newborn coverage.
The bill would further require the Department of Health to set reimbursement methodologies with an independent actuary, produce annual actuarial reports, and report each year to legislative leaders on program finances, enrollment, premiums, uninsured rates, Medicaid global cap effects, enrollment limits, and enrollee demographics. It also creates a framework for prioritizing enrollment if funding is limited, especially for lower-income individuals and certain high-need populations such as those with life-threatening conditions, transplant needs, or serious behavioral health conditions.
Overall, the bill appears aimed at expanding subsidized coverage options and stabilizing access for lower-income residents, including some immigrants who are otherwise excluded from existing coverage pathways. Because the bill text and context include no committee transcript or vote record, there is no documented floor or committee sentiment to assess; however, the sponsor list suggests strong support among Senate Democrats. The main points of contention likely concern federal waiver approval, the inclusion of noncitizens, fiscal exposure to the state, and whether the program’s enrollment limits and funding structure are sufficient to maintain solvency while expanding coverage.
The bill would amend Social Services Law section 369-ii to expand the structure of New York’s 1332 State Innovation Program and impose new duties on the Department of Health. It changes the commissioner’s role from permissive to mandatory in seeking federal waiver approval, adds detailed eligibility, enrollment, premium, and reporting rules, and creates special provisions for certain noncitizens, pregnant individuals, newborns, and high-need populations. It also affects how the state may finance and administer the program, including actuarial review, reimbursement methodology development, and possible transfers to the state innovation program fund.
No committee transcript or vote history is provided, so there is no recorded debate or roll-call sentiment to summarize. Based on the bill’s content and the large group of Democratic sponsors, the measure appears to reflect supportive sentiment toward expanding affordable coverage and protecting vulnerable populations. The absence of opposition statements in the provided materials means any controversy is inferred from the policy design rather than documented discussion.
The likely points of contention are fiscal and eligibility-related. Supporters would favor broader coverage, especially for low-income residents and certain noncitizens excluded from other programs, while critics may question the cost to the state, the reliance on federal waiver approval, and the program’s enrollment caps for immigration-status-based eligibility. Additional tension may arise over the requirement to cover cancer center services at Medicaid-equivalent rates, the use of state funds to support the program, and whether the annual reporting and actuarial controls are sufficient to manage risk and maintain budget neutrality.